2020 is the Fourth Consecutive Year XIFIN is Recognized by Black Book Research for Solution Excellence

This year has been unlike any other. Diagnostic providers have faced many challenges managing a rollercoaster of testing volume – with its associated claims and revenue implications – driven by COVID-19. XIFIN and its innovative laboratory solutions and services have played an important role in supporting these providers as they handle high testing volume and reimbursement challenges during the...

Read


Practical Approaches to Diagnostic RCM Digital Transformation

A lot has been written over the past several years about digital transformation. While there is agreement that digital transformation is a valuable investment, often it isn't easy to know where to start. The COVID-19 pandemic has so increased volume for many diagnostic laboratories that digital transformation is no longer an option. It is mandated to keep up with the pre-pandemic levels of...

Read


Enabling NGS Testing and Precision Medicine with Fabric AI Technologies

Enjoy the following content from our partner, Fabric Genommics. Next-Generation Sequencing (NGS) testing is experiencing tremendous growth driven at a high level by the promise of precision medicine and the life-changing power of applications in preventive genetic screening, somatic testing, and rare disease diagnosis. In all of these use cases, we see important clinical advances. Preventive...

Read


Digital Pathology Trends and the Impact of COVID-19 on Speed of Adoption

Digital pathology was introduced decades ago as a way for sharing digital images across laboratories, enabling pathologists to work together on cases and enhance the accuracy of diagnostic techniques. Before the COVID-19 pandemic, U.S. adoption of digital pathology lagged behind most other developed countries.The COVID-19 pandemic accelerated the adoption of digital pathology in this country for...

Read


Consider Closing Out the Year Strong With an Accounts Receivable (AR) Clean-up

Enjoy the following content from our partner, FrontRunnerHC. If you’re like most organizations, 2020 has impacted your patient volume and cash collection, so capturing every dollar of the revenue you’re entitled to is critical. Recently, I wrote an article featured in Beckers Hospital Review about three key reasons claims are piling up in your Accounts Receivable (AR) ledger. (To check out the...

Read


The CDC Offers a Multi-Virus Testing Option with the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay

With flu season typically starting in October and peaking between December and February, the Centers for Disease Control and Prevention (CDC) have developed two tests that identify the COVID-19 virus (SARS-CoV-2). The latest of these two tests, called the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay, tests for influenza A and B viruses as well as SARS-CoV-2.Along with the new test, the...

Read


XIFIN Client and Patient Portals Improve Retention and Accelerate Reimbursements

Typically, if a patient has a question about a bill they receive for laboratory testing, they must call the laboratory to get those questions answered. They also must call the laboratory to request a payment plan, if they cannot afford to pay their entire balance at once. In some cases, patients even need to call the laboratory to pay a balance by credit card.For larger laboratories, this means...

Read


The Cost of Preserving the Status Quo – It’s Not an All or Nothing Decision Anymore

Whether you’re a laboratory, pathology practice, molecular diagnostic provider, remote patient monitoring organization, or one of the nation’s largest hospitals offering ancillary services, factors causing revenue compression are threatening your bottom line. They include: Testing volume and reimbursement related to COVID-19. With volume initially dropping as much as 60% during the pandemic...

Read